Psychometric assessment of the PROMIS Fatigue Short Form 6a in women with moderate-to-severe endometriosis-associated pain
Open Access
- 27 October 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Patient-Reported Outcomes
- Vol. 4 (1), 1-10
- https://doi.org/10.1186/s41687-020-00257-y
Abstract
Endometriosis is a common problem in women of reproductive age and has impacts on health-related quality of life and productivity. Fatigue is an important part of the burden of endometriosis, it is not often included as an endpoint in clinical trials. The study assessed the psychometric properties of the PROMIS Fatigue Short Form 6a in women with moderate-to-severe endometriosis-associated pain. In a phase III double-blind, placebo-controlled clinical trial (NCT01620528), women aged 18–49 years with moderate-to-severe endometriosis-related pain were randomized to elagolix 150 mg once daily, elagolix 200 mg twice daily, or placebo for 6 months. PROMIS Fatigue and dysmenorrhea and non-menstrual pelvic pain (NMPP) scores were assessed at baseline and months 1, 3, and 6, and Patient Global Impression of Change (PGIC) was assessed at months 1, 3, and 6. Reliability (internal consistency and test-retest reliability), construct validity (convergent and known groups validity), and responsiveness were evaluated. The analysis included 871 women, mean age 31.5 years. Internal consistency supported a single concept (Cronbach’s alpha 0.93). For the 238 patients with no change in PGIC at month 1, the intraclass correlation coefficient for the PROMIS Fatigue T-score was 0.7 and paired t-test statistically significant (2.84, p = 0.0049). Correlations with other measures were expected to be fairly low as concepts were not redundant. The PROMIS Fatigue discriminated among known groups with mean scores of 55.3, 62.3, and 65.8 at month 3 (PGIC improvement, no change, worsening, respectively). Statically significant discrimination, and change score responsiveness, were seen using clinically relevant anchors (dysmenorrhea and NMPP) at months 3 and 6 between responders and non-responders. Anchor-based (PGIC) responsiveness showed significant improvement from baseline to months 3 and 6 (p < 0.0001). PROMIS Fatigue has good reliability, validity, and responsiveness in women with moderate-to-severe endometriosis-associated pain.Funding Information
- AbbVie (N/A)
This publication has 31 references indexed in Scilit:
- The influence of endometriosis-related symptoms on work life and work ability: a study of Danish endometriosis patients in employmentEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Six Patient-Reported Outcome Measurement Information System Short Form Measures Have Negligible Age- or Diagnosis-Related Differential Item Functioning in Individuals With DisabilitiesArchives of Physical Medicine and Rehabilitation, 2012
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countriesFertility and Sterility, 2011
- Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patientsJournal of Clinical Epidemiology, 2011
- Application of Patient-Reported Outcomes Measurement Information System to Chronic Pelvic PainJournal of Minimally Invasive Gynecology, 2011
- The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008Journal of Clinical Epidemiology, 2010
- Patients' report on how endometriosis affects health, work, and daily lifeFertility and Sterility, 2010
- Psychometric Evaluation and Calibration of Health-Related Quality of Life Item BanksMedical Care, 2007
- Development of an endometriosis quality-of-life instrument: The Endometriosis Health Profile-30Obstetrics & Gynecology, 2001
- Measuring the Functional Impact of Fatigue: Initial Validation of the Fatigue Impact ScaleClinical Infectious Diseases, 1994